Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and the resulting coronavirus disease-19 (COVID-19) have led to a global pandemic associated with high fatality rates. COVID-19 primarily manifests in the respiratory system as an acute respiratory distress syndrome following viral entry t...

Full description

Bibliographic Details
Main Authors: Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Evangelos Oikonomou, Kostas Tsioufis, Dimitris Tousoulis
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
COVID-19
SARS-CoV-2
inflammation
genetics
cytokines
Online Access:https://www.mdpi.com/2227-9059/10/2/242

Similar Items

Similar Items